Cardiac transthyretin/leukocyte chemotactic factor (LECT) 2 double amyloidosis in a patient suffering from heart failure
Clin Res Cardiol
.
2023 Mar;112(3):444-449.
doi: 10.1007/s00392-022-02045-8.
Epub 2022 Aug 4.
Authors
Simon Greulich
1
,
Heiko Mahrholdt
2
,
Rita Casadonte
3
,
Lars Steinmüller-Magin
4
,
Joerg Latus
5
,
Frithjof Blessing
4
,
Joerg Kriegsmann
3
,
Raffi Bekeredjian
6
,
Meinrad Gawaz
1
,
Karin Klingel
7
Affiliations
1
Department of Cardiology and Angiology, Eberhard Karls Universität Tübingen, Tübingen, Germany.
2
Department of Cardiology and Angiology, Robert Bosch Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany. Heiko.Mahrholdt@icloud.com.
3
Proteopath GmbH, Trier, Germany.
4
Institute of Laboratory Medicine and Human Genetics, Singen, Germany.
5
Department of Nephrology, Klinikum Stuttgart, Stuttgart, Germany.
6
Department of Cardiology and Angiology, Robert Bosch Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany.
7
Cardiopathology, Institute for Pathology and Neuropathology, Eberhard Karls Universität Tübingen, Tübingen, Germany.
PMID:
35925392
DOI:
10.1007/s00392-022-02045-8
No abstract available
Publication types
Letter
MeSH terms
Amyloid Neuropathies, Familial*
Amyloidosis* / complications
Amyloidosis* / diagnosis
Cardiomyopathies*
Heart
Heart Failure* / diagnosis
Heart Failure* / etiology
Humans
Prealbumin / genetics
Substances
Prealbumin